New global estimates map a largely unrecorded burden of snake envenoming
An analysis of evidence from 79 countries and a geostatistical model estimates that at least 2.1 million people experience snake envenoming each year, with the total potentially reaching 7 million. Modeled annual deaths range from 274,000 to 513,000, and sub-Saharan Africa accounts for an estimated 45% of envenomings and deaths. The country-level risk maps are intended to help target antivenom, trained health workers and transport support.
The story
Researchers reviewed snakebite evidence from 79 countries, drawing on studies published up to March 31, 2025, to update a global assessment last conducted in 2008. Because many countries do not record all bites or envenomings, the team also built a geostatistical model using climate, venomous-snake species richness and socioeconomic indicators. It compared hospital and regional records with community-survey evidence to account for cases that do not enter national health statistics. The analysis estimates that at least 2.1 million people experience snake envenoming annually worldwide; the authors’ upper estimate is 7 million. Their modeled range for annual deaths is 274,000 to 513,000. Sub-Saharan Africa is estimated to carry 45% of global envenomings and fatalities, with envenoming and death rates nearly three times those in South Asia. Nigeria, the Democratic Republic of the Congo and Ethiopia are identified as high-burden countries. The source also estimates that more than 800,000 survivors have long-term physical disabilities each year, including amputations and other permanent impairments. The researchers propose using spatial risk information to guide antivenom placement, rural health-worker training and transport planning.
Why it matters
Health statistics that rely primarily on clinic records can miss people who live far from facilities, cannot afford travel or seek traditional care. That can leave decision-makers allocating treatment with an incomplete view of demand. Risk estimates at a more local level offer a basis for matching antivenom supply and emergency capacity to rural agricultural areas where exposure is high. The maps do not provide care themselves, but they can make gaps in reporting and service coverage more visible to health planners.
Evidence and context
A snakebite does not always inject venom, but venom entering the body can cause snake envenoming, a potentially fatal condition concentrated in poor rural communities in tropical and subtropical regions. The source describes a combination of exposure and care barriers: agricultural workers may work without protective boots or travel on unlit paths, while long distances, fragile health systems and unavailable or costly antivenom can delay treatment. Sub-Saharan Africa also has a wide range of medically important venomous snakes, including saw-scaled vipers, puff adders, cobras and mambas. The World Health Organization has set a goal of halving snakebite mortality and disability by 2030; the new estimates frame where that response may need to be concentrated.
Limits and unknowns
These findings are modeled ranges, not a worldwide census of confirmed cases. The source says that more than half of countries where venomous snakes pose a threat do not count bites or envenomings, and the literature review ended on March 31, 2025. Geostatistical estimates use observed data alongside environmental and socioeconomic signals to fill gaps, so results remain sensitive to the availability and quality of hospital records and community surveys. It remains uncertain how closely estimates represent individual localities with little or no direct reporting.
What happens next
Ahead of the World Health Organization’s 2030 target, watch for national snakebite plans that use local risk mapping to place antivenom and train frontline workers. Useful evidence would include improved reporting from rural communities, treatment availability at nearby facilities and changes in travel time to emergency care.
Follow the story
Share it, watch the explainer, or continue with the reporting trail.
Story timeline
Earlier global burden assessment
The researchers describe their analysis as an update to a 2008 global burden study.
Evidence-review cutoff
The analysis reviewed studies published up to this date.
WHO target
The World Health Organization aims to halve snakebite mortality and disability by this year.
Further reading on this topic
2 links
New global estimates map a largely unrecorded burden of snake envenoming
A short visual explainer for readers who want the story in a different rhythm.
Highlights
- Rural risk, newly mapped
- Evidence from 79 countries
- At least 2.1 million a year
- A guide for rural care
Transcript
New country-level maps offer a clearer picture of snake envenoming risk in overlooked rural areas.
Researchers combined evidence from 79 countries with climate and snake data to model unreported cases.
Their model estimates at least 2.1 million envenomings yearly, with 45 percent in sub-Saharan Africa.
The maps could help rural communities by guiding antivenom supplies, health-worker training, and transport planning.
The numbers are modeled, and many countries don't count bites; improving rural reporting comes next.